Author

Abdel Elkahloun

National Human Genome Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Christina TatsiiD· 1 shared Clarisse QuignoniD· 1 shared Daniela Tortoza Lopez· 1 shared David T. AsuzuiD· 1 shared Debjani MandaliD· 1 shared Dhruval Bhatt· 1 shared Diana Nwokoye· 1 shared Dragan MariciD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Christina TatsiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Phosphoproteomic dysregulation drives tumor proliferation in Cushing's disease

David T. Asuzu, Dhruval Bhatt, Dustin Mullaney, Debjani Mandal, Diana Nwokoye, Sheelu Varghese, Daniela Tortoza Lopez, Nikhil Ramavenkat, Kory Johnson, Abdel Elkahloun, Zied Abdullaev, Kenneth Aldape, Dragan Maric, Clarisse Quignon, N MALIK, , Prashant Chittiboina

This study identifies phosphoproteomic dysregulation as a driver of tumor proliferation in Cushing's disease and demonstrates reversibility using an FDA-approved PP2A agonist.

bioRxiv · Sep 28, 2025 · PreprintCancer Biology